MECP2 Duplication Foundation

MECP2 Duplication Foundation The MECP2 Duplication Foundation is a family founded organization providing support to the MECP2 Duplication community.

Another site has been activated in the Ionis ATTUNE trial! ⁣⁣A new site is now open in Barcelona, Spain, becoming the 11...
03/24/2026

Another site has been activated in the Ionis ATTUNE trial! ⁣

A new site is now open in Barcelona, Spain, becoming the 11th site in the trial.⁣

Along with 8 sites in the U.S., there are two other international locations in France & Austria. We look forward to more sites in the future! 🌍

02/28/2026

Today on Rare Disease Day, we stand with families affected by MECP2 Duplication Syndrome 💜On this Rare Disease Day, we r...
02/28/2026

Today on Rare Disease Day, we stand with families affected by MECP2 Duplication Syndrome 💜

On this Rare Disease Day, we raise awareness, support families, and push for progress. No one should face rare alone.

Today we stand with the 300+ million people worldwide living with a rare disease 💜On Rare Disease Day, we support every ...
02/28/2026

Today we stand with the 300+ million people worldwide living with a rare disease 💜

On Rare Disease Day, we support every individual, every family, and every community navigating the challenges of a rare diagnosis — including those affected by MECP2 Duplication Syndrome and thousands of other conditions.

🔬 Rare is not uncommon.
💜 Rare is resilient.
🌍 Rare deserves awareness, research, and support.

Together, we raise our voices, advocate for progress, and remind the world that no one should face rare alone.

Mark your calendars! We can’t wait to see you at the next family conference. More details--including hotel, registration...
02/21/2026

Mark your calendars! We can’t wait to see you at the next family conference. More details--including hotel, registration, and agenda--coming soon!

Looking to "Share Your Rare" this week?There are many ways to raise awareness, one is to post the "Love Someone" image b...
02/21/2026

Looking to "Share Your Rare" this week?

There are many ways to raise awareness, one is to post the "Love Someone" image below and another is to use the attached Canva link to create a facebook profile picture from the template.

1. Click the link and log into Canva
2. Upload your desired picture
3. Drag the picture into the "landscape" until it fits the background
4. Double click the image to crop your picture
5. Download with the "Share" button

Then you are ready for a "rare" MDS profile picture.

Canva Link: https://www.canva.com/design/DAHB7NPFK1g/iQLNw1Yp3eHBHIMz14PFKQ/view?utm_content=DAHB7NPFK1g&utm_campaign=designshare&utm_medium=link&utm_source=publishsharelink&mode=preview

You can also PM us directly and we can help create your profile picture.

February 28th is Rare Disease Day! Rare disease day is an opportunity to shine a light on MECP2 Duplication Syndrome as ...
02/12/2026

February 28th is Rare Disease Day!

Rare disease day is an opportunity to shine a light on MECP2 Duplication Syndrome as well as the greater rare community.

This Rare Disease Day, we invite you to help us raise awareness in whatever way feels right and accessible to you.

If you’re able, consider wearing zebra stripes, sharing a fact about MECP2 Duplication Syndrome, posting a photo, or starting a conversation. If you’re not able to participate, simply learning and helping others understand still makes a meaningful difference.

Every share, every conversation, and every moment of understanding helps spread knowledge, compassion, and hope. 💙

Wow, 2025 turned out to be a big year for moving forward as we—⁣⁣✅ Moved potential therapies closer to families through ...
12/31/2025

Wow, 2025 turned out to be a big year for moving forward as we—⁣

✅ Moved potential therapies closer to families through strong industry partnerships that supported natural history work and clinical trials ⁣

✅ Offered family support grants to get much-needed funds to those traveling for medical visits or facing a stay in the hospital⁣

✅ Began a dialogue with the FDA so regulators include our voices in their decision-making ⁣

✅ Collaborated on a global MECP2 Duplication alliance to work faster and smarter together ⁣

✅ Developed new educational resources with more launching soon ⁣

✅ Attended & presented at conferences to strengthen research, share knowledge with families, and raise awareness with clinicians⁣

✅ Supported research that sheds new light on MECP2 Duplication Syndrome⁣

We are grateful to our community and our partners—and we look forward to 2026 with determination and belief in the possibilities of what’s to come.⁣

Happy new year, and here’s to an even stronger year ahead!⁣

In this 2-part series, we share more insights from a definitive new study of epilepsy in MECP2 Duplication Syndrome—⁣⁣👶 ...
12/30/2025

In this 2-part series, we share more insights from a definitive new study of epilepsy in MECP2 Duplication Syndrome—⁣

👶 Age of onset is associated with other symptoms.⁣
Seizures tended to begin earlier in children with:⁣

• Hypotonia in the first year of life⁣

• Microcephaly⁣

🔗 Development and seizures are connected. ⁣
Seizures were strongly associated with developmental regression, defined in this study as the permanent loss of previously acquired gross motor skills. ⁣

Children with seizures who achieved milestones—such as rolling over, pulling up, standing independently, and walking—frequently lost these abilities as they aged, did not regain them, and did not progress to higher skill levels. ⁣

Kids with atonic or mixed seizure types experienced earlier and more pronounced loss of physical abilities. ⁣

Atonic (drop) seizures were associated with the loss of gross motor skills in concert with seizure onset. ⁣

🔍 This study doesn’t just add new information. ⁣
It maps complexity and establishes the most comprehensive understanding to date by showing that epilepsy is:⁣

• A core feature of the condition—with a major impact on health and quality of life ⁣

• Hard to treat, often becoming refractory ⁣

• Closely connected to developmental outcomes, particularly gross motor regression ⁣

Research like this supports clinical trials by delineating the science behind what families live with every day. It shows just what our community shared with the FDA earlier this year: the unmet need for targeted treatment is serious and urgent.⁣

Even more importantly, this research can serve as the new standard in understanding the natural history of epilepsy in MECP2 Duplication Syndrome—providing a critical reference to determine whether an experimental treatment really works. ⁣

Check out new research—offering the most detailed understanding of epilepsy in MECP2 Duplication Syndrome yet!⁣⁣In a lan...
12/28/2025

Check out new research—offering the most detailed understanding of epilepsy in MECP2 Duplication Syndrome yet!⁣

In a landmark analysis, a team from Ionis and Citizen examined real medical records from 50 people to learn how seizures and development unfold as children age.⁣

Key insights:⁣

⚡️ Seizures are extremely common. ⁣
Most kids with MECP2 Duplication Syndrome experience seizures—often beginning in early childhood (median onset ~7 years). By adolescence, more than 85% of participants develop seizures. Of all seizure types, atonic (drop) were the most common.⁣

🧠 Seizures usually become severe and difficult to control.⁣
Many participants:⁣

• Experienced multiple types of seizures, such tonic-clonic, atonic, absence, myoclonic, focal, and epileptic spasms⁣

• Tried many any-seizure medications⁣

• Ultimately used several different types in an effort to manage seizures that frequently become treatment-resistant—with levitiracetam (often called Keppra) and diazepam (such as Valtoco or Nayzilam) prescribed most often⁣

In this group, 20% of participants were eventually diagnosed with Lennox Gastaut Syndrome. ⁣

🏥 Seizure burden is high. ⁣
Daily or weekly seizures were common, requiring at least one seizure-related hospitalization. Admission typically lasted up to a week—highlighting the challenges of seizure management.⁣

Thanks to the researchers who have set this new benchmark—and especially to all the families who made this study possible by participating in the Citizen online natural history study. Stay tuned for Part 2 to learn more!⁣

Address

Tucson, AZ

Alerts

Be the first to know and let us send you an email when MECP2 Duplication Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to MECP2 Duplication Foundation:

Share